Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10113179 Compositions and methods for modifying genomes
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Date Filed
November 8, 2017
Date of Patent
October 30, 2018
Patent Application Number
15806890
Patent Citations Received
US Patent 12110545 Methods of assessing nuclease cleavage
0
US Patent 11920140 Organelle genome modification using polynucleotide guided endonuclease
0
US Patent 11499151 Methods and systems for analyzing guide RNA molecules
US Patent 11236313 Cas9 fusion molecules, gene editing systems, and methods of use thereof
US Patent 11597924 Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
US Patent 11273442 Programmable nuclease compositions and methods of use thereof
US Patent 11667911 Use of exonucleases to improve CRISPR/CAS-mediated genome editing
0
US Patent 11680268 Methods for improving CRISPR/Cas-mediated genome-editing
0
US Patent 11761029 Programmable nuclease compositions and methods of use thereof
US Patent 11390884 Optimized CRISPR/cas9 systems and methods for gene editing in stem cells
•••
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
10113179
Patent Primary Examiner
Brent T Page
Find more entities like US Patent 10113179 Compositions and methods for modifying genomes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE